174 related articles for article (PubMed ID: 6875019)
1. The value of screening blood donors for antibody to hepatitis B core antigen.
Archer AC; Cohen BJ; Mortimer PP
J Clin Pathol; 1983 Aug; 36(8):924-8. PubMed ID: 6875019
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B core antibody in volunteer blood donors: comparison of radioimmunoassay and indirect immunofluorescence.
Katchaki JN; Siem TH; Brouwer R
J Med Virol; 1979; 3(4):275-80. PubMed ID: 383904
[TBL] [Abstract][Full Text] [Related]
3. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
[TBL] [Abstract][Full Text] [Related]
4. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
Muselmani W; Habbal W; Monem F
Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
[TBL] [Abstract][Full Text] [Related]
5. Comparison of radioimmunoassay and counter-immunoelectrophoresis for the detection of antibody to hepatitis B core antigen.
Cohen BJ; Hewish RA; Mortimer PP
J Virol Methods; 1981 Feb; 2(3):181-92. PubMed ID: 7276128
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibody to Hepatitis B core antigen and Hepatitis B virus DNA in HBsAg negative healthy blood donors.
Karimi G; Zadsar M; Vafaei N; Sharifi Z; FalahTafti M
Virol J; 2016 Mar; 13():36. PubMed ID: 26944046
[TBL] [Abstract][Full Text] [Related]
8. Performance of an algorithm for the reentry of volunteer blood donors deferred due to false-positive test results for antibody to hepatitis B core antigen.
Katz L; Strong DM; Tegtmeier G; Stramer S
Transfusion; 2008 Nov; 48(11):2315-22. PubMed ID: 18647367
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and significance of anti-HBc IgM (radioimmunoassay) in acute and chronic hepatitis B and in blood donors.
Bänninger P; Altorfer J; Frösner GG; Pirovino M; Gudat F; Bianchi L; Grob PJ; Schmid M
Hepatology; 1983; 3(3):337-42. PubMed ID: 6341197
[TBL] [Abstract][Full Text] [Related]
10. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
11. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.
van de Laar TJ; Marijt-van der Kreek T; Molenaar-de Backer MW; Hogema BM; Zaaijer HL
Transfusion; 2015 Jun; 55(6):1206-13. PubMed ID: 25494685
[TBL] [Abstract][Full Text] [Related]
12. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
[TBL] [Abstract][Full Text] [Related]
13. Current tests for antibody to hepatitis b core antigen used to screen donors for non-A, non-B hepatitis are comparable to the original radioimmunoassay for hepatitis B core antigen.
Troisi CL; Hollinger FB
Transfusion; 1987; 27(5):438-40. PubMed ID: 3114923
[TBL] [Abstract][Full Text] [Related]
14. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
[TBL] [Abstract][Full Text] [Related]
15. [Anti-core antibody in HBsAg negative subjects].
Ferroni P; Quartodipalo ME; Zanetti AR
Boll Ist Sieroter Milan; 1978 Nov; 57(5):676-9. PubMed ID: 556542
[TBL] [Abstract][Full Text] [Related]
16. Occult hepatitis B virus infection among Iranian blood donors: a preliminary study.
Alizadeh Z; Milani S; Sharifi Z
Arch Iran Med; 2014 Feb; 17(2):106-7. PubMed ID: 24527970
[TBL] [Abstract][Full Text] [Related]
17. Blood donors positive for HBsAg and negative for anti-HBc antibody.
Couroucé AM; Drouet J; LeMarrec N; Drouet A; Soulier JP
Vox Sang; 1985; 49(1):26-33. PubMed ID: 4013141
[TBL] [Abstract][Full Text] [Related]
18. Detection and significance of anti-HBc in the blood bank; preliminary results of a controlled prospective study.
Katchaki JN; Siem TH; Brouwer R; Brandt KH; van der Waart M
J Virol Methods; 1980 Dec; 2(1-2):119-25. PubMed ID: 7228974
[TBL] [Abstract][Full Text] [Related]
19. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
[TBL] [Abstract][Full Text] [Related]
20. Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?
Stramer SL; Zou S; Notari EP; Foster GA; Krysztof DE; Musavi F; Dodd RY
Transfusion; 2012 Feb; 52(2):440-6. PubMed ID: 21810101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
